Acura Pharmaceuticals, Inc. (OTCMKTS:ACUR – Get Free Report) crossed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.01 and traded as low as $0.00. Acura Pharmaceuticals shares last traded at $0.00, with a volume of 52,127 shares traded.
Acura Pharmaceuticals Stock Performance
About Acura Pharmaceuticals
Acura Pharmaceuticals, Inc, an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products.
Recommended Stories
- Five stocks we like better than Acura Pharmaceuticals
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- 3 Legacy Tech Companies Reemerging as AI Leaders
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Analysts’ Favorite Cybersecurity Stocks: 3 Top Picks
- 3 Healthcare Dividend Stocks to Buy
- Analysts Are Bullish: 3 Tech Giants With Upgraded Price Targets
Receive News & Ratings for Acura Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acura Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
